Epigenomics AG (ECX):企業の製品パイプライン分析

◆英語タイトル:Epigenomics AG (ECX) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME7911PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi proLung, a validating test for the diagnosis of lung cancer. The company’s molecular diagnostic products are based on its proprietary methylation technology, which is based on biological phenomenon called DNA methylation. The company also offers Epi BiSKit, a pre-analytical kit for the preparation of bisulfite-converted DNA, and HCCBloodTest for the detection of hepatocellular carcinoma (HCC). Epigenomics is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Epigenomics AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Epigenomics AG Company Overview
Epigenomics AG Company Snapshot
Epigenomics AG Pipeline Products and Ongoing Clinical Trials Overview
Epigenomics AG – Pipeline Analysis Overview
Business Description
Epigenomics AG – Key Facts
Epigenomics AG – Major Products and Services
Epigenomics AG Pipeline Products by Development Stage
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG Pipeline Products Overview
Biomarker PITX2 – Prostate Cancer Prognosis
Biomarker PITX2 – Prostate Cancer Prognosis Product Overview
Blood – Based Lung Cancer Test
Blood – Based Lung Cancer Test Product Overview
Epi proColon 1.0
Epi proColon 1.0 Product Overview
HCCBloodTest
HCCBloodTest Product Overview
HCCBloodTest Clinical Trial
NGS Panel – Bladder Cancer
NGS Panel – Bladder Cancer Product Overview
NGS Panel – Breast Cancer
NGS Panel – Breast Cancer Product Overview
NGS Panel – Colorectal Cancer
NGS Panel – Colorectal Cancer Product Overview
NGS Panel – Lung Cancer
NGS Panel – Lung Cancer Product Overview
NGS Panel – Ovarian Cancer
NGS Panel – Ovarian Cancer Product Overview
NGS Panel – Prostate Cancer
NGS Panel – Prostate Cancer Product Overview
Epigenomics AG – Key Competitors
Epigenomics AG – Key Employees
Epigenomics AG – Key Employee Biographies
Epigenomics AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Epigenomics AG, Recent Developments
Nov 29, 2019: New micro-simulation study in cancer medicine finds Epi proColon provides clinically meaningful reductions in incidence and mortality of colorectal cancer
Nov 19, 2019: Epigenomics reports financial results for the first nine months 2019
Aug 07, 2019: Epigenomics highlights operational achievements and reports financial results for first six months 2019
Jul 24, 2019: Study published in American Health Drug Benefits suggests that non-invasive screening methods, including Epi proColon, could be a cost-effective option to help achieve target U.S. colorectal cancer screening rates
Jul 11, 2019: Epigenomics receives MedTech Outlook’s 2019 top 10 in-vitro diagnostics award
Jun 17, 2019: New clinical data support the utility of Epi proColon blood test for colorectal cancer screening in patients with Lynch Syndrome, the most common hereditary CRC Syndrome
May 19, 2019: New report shows CRC screening rates increased when a medically underserved population is offered Epi proColon Blood Test
May 09, 2019: Epi proColon receives the 2019 Excellence in Molecular Diagnostics Award
May 08, 2019: Epigenomics announces 2019 first quarter financial results
May 03, 2019: CMS accepts Epigenomics’ application for NCD review
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Epigenomics AG Pipeline Products and Ongoing Clinical Trials Overview
Epigenomics AG Pipeline Products by Equipment Type
Epigenomics AG Pipeline Products by Indication
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG, Key Facts
Epigenomics AG, Major Products and Services
Epigenomics AG Number of Pipeline Products by Development Stage
Epigenomics AG Pipeline Products Summary by Development Stage
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG Ongoing Clinical Trials Summary
Biomarker PITX2 - Prostate Cancer Prognosis - Product Status
Biomarker PITX2 - Prostate Cancer Prognosis - Product Description
Blood - Based Lung Cancer Test - Product Status
Blood - Based Lung Cancer Test - Product Description
Epi proColon 1.0 - Product Status
Epi proColon 1.0 - Product Description
HCCBloodTest - Product Status
HCCBloodTest - Product Description
HCCBloodTest - A Multi-center Validation and Development Study of Methylated Cell-free DNA Biomarkers to Aid in the Detection of Hepatocellular Carcinoma in Patients with Cirrhosis
NGS Panel - Bladder Cancer - Product Status
NGS Panel - Bladder Cancer - Product Description
NGS Panel - Breast Cancer - Product Status
NGS Panel - Breast Cancer - Product Description
NGS Panel - Colorectal Cancer - Product Status
NGS Panel - Colorectal Cancer - Product Description
NGS Panel - Lung Cancer - Product Status
NGS Panel - Lung Cancer - Product Description
NGS Panel - Ovarian Cancer - Product Status
NGS Panel - Ovarian Cancer - Product Description
NGS Panel - Prostate Cancer - Product Status
NGS Panel - Prostate Cancer - Product Description
Epigenomics AG, Key Employees
Epigenomics AG, Key Employee Biographies
Epigenomics AG, Subsidiaries
Glossary

★海外企業調査レポート[Epigenomics AG (ECX):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shinhan Bank:企業の戦略・SWOT・財務分析
    Shinhan Bank - Strategy, SWOT and Corporate Finance Report Summary Shinhan Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Svenska Handelsbanken AB:企業のM&A・事業提携・投資動向
    Svenska Handelsbanken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Handelsbanken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • QIC Ltd:企業の戦略・SWOT・財務情報
    QIC Ltd - Strategy, SWOT and Corporate Finance Report Summary QIC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Facebook Inc (FB):企業の財務・戦略的SWOT分析
    Facebook Inc (FB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • TransMontaigne Product Services LLC:戦略・SWOT・企業財務分析
    TransMontaigne Product Services LLC - Strategy, SWOT and Corporate Finance Report Summary TransMontaigne Product Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • North Central Electric Cooperative, Inc.:企業の戦略的SWOT分析
    North Central Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Banco BPI, S.A.:企業のM&A・事業提携・投資動向
    Banco BPI, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco BPI, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • The Kansai Electric Power Company Inc (9503)-エネルギー分野:企業M&A・提携分析
    Summary The Kansai Electric Power Company Inc (KEPCo) is an integrated power utility. The company produces and supplies electricity; and procures and sells natural gas. It generates electricity from natural gas, oil, nuclear, coal, hydro, wind, and solar sources. Through long, medium, and short term …
  • Parker Hannifin Corporation (PH)-石油・ガス分野:企業M&A・提携分析
    Summary Parker Hannifin Corporation (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions including fluid power systems, electromechanical controls and related components. Its products find use in various industries and ap …
  • FPT Securities Joint Stock Company (FTS):企業の財務・戦略的SWOT分析
    FPT Securities Joint Stock Company (FTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Saras SpA (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Emory Healthcare Corporate:製薬・医療:M&Aディール及び事業提携情報
    Summary Emory Healthcare Corporate (Emory Healthcare) is a healthcare service provider. The center offers treatments such as acl injuries, aging, als and related conditions, bleeding disorders, bone and tissue tumors, brain health, cancer conditions, dental implants, dermatology, digestive diseases; …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Walmart Inc:企業のM&A・事業提携・投資動向
    Walmart Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Walmart Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Xcel Energy Inc:発電所・企業SWOT分析
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆